Related references
Note: Only part of the references are listed.Artemether-Lumefantrine Pharmacokinetics and Clinical Response Are Minimally Altered in Pregnant Ugandan Women Treated for Uncomplicated Falciparum Malaria
Myaing M. Nyunt et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Pharmacokinetic studies of antimalarials: recent developments
Timothy M. E. Davis
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2016)
Antiretroviral Choice for HIV Impacts Antimalarial Exposure and Treatment Outcomes in Ugandan Children
Sunil Parikh et al.
CLINICAL INFECTIOUS DISEASES (2016)
Parasite Clearance and Artemether Pharmacokinetics Parameters Over the Course of Artemether-Lumefantrine Treatment for Malaria in Human Immunodeficiency Virus (HIV)-Infected and HIV-Uninfected Ugandan Children
Richard Kajubi et al.
Open Forum Infectious Diseases (2016)
Investigation of the Functional Role of P-Glycoprotein in Limiting the Oral Bioavailability of Lumefantrine
Wahajuddin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Efficacy and Day 7 Plasma Piperaquine Concentrations in African Children Treated for Uncomplicated Malaria with Dihydroartemisinin-Piperaquine
Issaka Zongo et al.
PLOS ONE (2014)
Protective Efficacy and Safety of Three Antimalarial Regimens for the Prevention of Malaria in Young Ugandan Children: A Randomized Controlled Trial
Victor Bigira et al.
PLOS MEDICINE (2014)
Population Pharmacokinetics of Lumefantrine in Pregnant and Nonpregnant Women With Uncomplicated Plasmodium falciparum Malaria in Uganda
F. Kloprogge et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2013)
Concomitant Efavirenz Reduces Pharmacokinetic Exposure to the Antimalarial Drug Artemether-Lumefantrine in Healthy Volunteers
Liusheng Huang et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2012)
Lopinavir/ritonavir significantly influences pharmacokinetic exposure of artemether/lumefantrine in HIV-infected Ugandan adults
Pauline Byakika-Kibwika et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Antiretroviral Agents and Prevention of Malaria in HIV-Infected Ugandan Children
Jane Achan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Determination of lumefantrine in small-volume human plasma by LC-MS/MS: using a deuterated lumefantrine to overcome matrix effect and ionization saturation
Liusheng Huang et al.
BIOANALYSIS (2012)
Comparison of plasma, venous and capillary blood levels of piperaquine in patients with uncomplicated falciparum malaria
Elizabeth A. Ashley et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Lopinavir/Ritonavir Affects Pharmacokinetic Exposure of Artemether/Lumefantrine in HIV-Uninfected Healthy Volunteers
Polina German et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2009)
Understanding the pharmacokinetics of Coartem (R)
Abdoulaye Djimde et al.
MALARIA JOURNAL (2009)
How can we do pharmacokinetic studies in the tropics?
JA Simpson et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2001)
Share Paper
